Apr 22 |
US Supreme Court Declines To Hear Vanda Pharmaceuticals' Case Regarding Invalidation Of Patents For Its Sleep Disorder Drug, Hetlioz
|
Apr 22 |
UPDATE 1-U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents
|
Apr 21 |
11 Best Low Price Pharma Stocks To Invest In
|
Apr 19 |
Alvotech/Teva bring new partner to expand access for Humira biosimilar in U.S.
|
Apr 19 |
Zacks Industry Outlook Highlights Teva, Dr. Reddy's and Viatris
|
Apr 18 |
3 Generic Drug Stocks to Watch Amid Challenging Market Prospects
|
Apr 16 |
FDA approves Alvotech biosimilar of J&J top-selling drug Stelara
|
Apr 16 |
Alvotech and Teva Announce U.S. FDA Approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Stelara® (ustekinumab)
|
Apr 16 |
Teva’s New Real-World Evidence Presented at the 2024 AAN Annual Meeting Confirms Effectiveness and Patient Satisfaction for HD Chorea with the 4-week Titration Kit for AUSTEDO® (deutetrabenazine) Tablets
|
Apr 15 |
Israeli economy has proven to thrive despite crisis: Expert
|